Name: Class: Date:vg
Chaptervg1vgConsumervgSafetyvgandvgDrugvgRegulat
ions
1. Avgclientvgcallsvghervgprimaryvgcarevgprovidervgrequestingvgavgprescriptionvgforvganvgantidepressantvgmedication.vg
Shevgtellsvgthevgnursevgthatvgshevgisvgseverelyvgdepressedvgandvgwouldvglikevgthevgprescriptionvgcalledvginvgtovghervgloc
alvgpharmacy.vgHowvgshouldvgthevgnursevgrespond?
a. Thevgnursevgencouragesvgthevgclientvgtovgseevgavgpsychiatricvgprofessionalvgforvganvgevaluationvgtovg
obtainvgthevgprescription.
b. Thevgnursevgtellsvgthevgclientvgtovgaskvgthevgpharmacistvgtovgrecommendvganvgover-the-countervgantidepressant.
c. Thevgnursevgcanvgoffervgtovgwritevgthevgclientvgavgprescriptionvgifvgitvg isvgavgrefill.
d. Thevgnursevgoffersvgtovggivevgthevgclientvgavgfewvgsamplesvgtovgusevguntilvghervgnextvgappointment.
ANSWER: a
FEEDBACK:
a.vgThevgclientvgshouldvgbevgencouragedvgtovgseekvgavgpsychiatricvgprofessionalvgevalu
ationvgtovgobtainvgthevgprescription.
b. Antidepressantsvgarevgnotvgsoldvgasvgover-the-
countervgmedications;vgavgprescriptionvgisvgrequired.vgTryvgagain.
c. Thevgnursevgcannotvgwritevgavgprescriptionvgwithoutvgevaluatingvgthevgclient.vgTryvgagain.
d. Samplesvgarevgnotvggivenvgoutvgtovgavgclientvgwhovghasvgnotvgbeenvgevaluatedvgbyvgavgpra
ctitioner.vgTryvgagain.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgChoice
HASvgVARIABLES:v g False
DATEvgCREATED: 11/26/2017vg8:16vgPM
DATEvgMODIFIED:v g 11/26/2017vg8:32vgPM
2. Avgclientvgvisitsvghervghealthvgcarevgprovidervgforvghervgannualvgphysical.vgShevgquestionsvgthevgnursevgregardingv
gthevgusevgofvganvgherbalvgsupplementvgthatvgshevgsawvgadvertisedvgonvgtelevisionvgforvgweightvgloss.vgWhatvginforma
tionvgcanvgthevgnursevgsharevgwithvghervgclient?
a. ThevgproductionvgofvgherbalvgmedicinesvgisvgnotvgregulatedvgbyvgthevgFDA.
b. UndervgthevgDietaryvgSupplementvg HealthvgandvgEducationvgActvgofvg1994vg(DSHEA),vgthevgFDAvgisvgres
ponsiblevgforvgensuringvgthatvg avgdietaryvgsupplementvg isvgsafevgbeforevgitvgisvgmarketed.
c. HerbalvgmedicinesvgarevgtestedvgbyvgthevgFDAvgtovgdeterminevgifvgtheyvghavevginteractionsvgwithvgpr
escribedvgmedications.
d. Herbalvgmedicines,vgwhilevgnotvgapprovedvgbyvgthevgFDA,vgarevgconsideredvgharmless.
ANSWER: a
FEEDBACK: a.vgThevgproductionvgofvg herbalvgmedicinesvgisvgnotvgregulatedvgbyvgthevgFDA.
b. UndervgthevgDietaryvgSupplementvgHealthvgandvgEducationvgActvgofvg1994vg(DSHEA),vgt
hevgdietaryvgmanufacturervgisvgresponsiblevgforvgensuringvgthatvgavgdietaryvgsupplementvgi
svgsafevgbeforevgitvgisvgmarketed.vgTryvgagain.
c. ThevgFDAvgdoesvgnotvgtestvgsupplements.vgTryvgagain.
d. Therevgarevgdocumentedvginteractionsvgwithvgspecificvgherbalvgsupplementsvgandvgpre
scribedvgmedications.vgTryvgagain.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgChoice
HASvgVARIABLES:v g False
DATEvgCREATED: 11/26/2017vg8:22vgPM
DATEvgMODIFIED:v g 11/26/2017vg8:32vgPM
CopyrightvgCengagevgLearning.vgPoweredvgbyvgCog Pagevg1
nero.
,Name: Class: Date:vg
Chaptervg1vgConsumervgSafetyvgandvgDrugvgRegulat
ions
3. Uponvgleavingvgthevgexamvgroom,vgavgclientvgtellsvgthevgnursevgthatvgshevgisvgconfusedvgregardingvghervgprescription.
Shevgasksvgthevgnursevgifvgavgcheaper,vggenericvgdrugvgwillvgbevgweakervgthanvghervgcurrentvgprescription.vgHowvgshou
vg
ldvgthevgnursevgrespond?
a. Drugvgstandardsvgassurevgconsumersvgthatvgthevgsamevgdrugvgmustvgbevgofvguniformvgstrength,vgquality,vgandvgpur
ity.
b. Thevgprescribedvgmedicationvgisvgofvgbettervgqualityvgbutvgwillvgcostvgmore.
c. Thevginsurancevgcompaniesvgmandatevgtherevgarevgdifferentvgstrengthsvgbetweenvggenericvgandvgbran
dvgnamevgprescriptions.
d. Everyvgdrugvghasvgavgdifferentvgchemicalvgcompositionvgthatvgcannotvgbevgduplicated.
ANSWER: a
FEEDBACK:
a.vgDrugvgstandardsvgassurevgconsumersvgthatvgthevgsamevgdrugvgmustvgbevgofvgun
iformvgstrength,vgquality,vgandvgpurity.
b. Genericvgandvgtradevgdrugsvgarevgthevgsamevgmedication.vgGenericvgisvgthevgnamevgthatvgi
svgassignedvgtovgavgnewvgdrug.vgThevgtradevgnamevgisvgthevgnamevgthevgpharmaceuticalvgco
mpanyvgassignsvgtovgthatvgdrugvgtovghavevgexclusivevgrightsvgtovgmarketvgit.vgTryvgagain.
c. Insurancevgcompaniesvghavevgnovgcontrolvgovervgthevgproductionvgofvgmedication.vgTryvgagain.
d. Thevglawsvgregulatingvgdrugsvgstatevgthatvgconsumersvgcanvgbevgassuredvgthatvgallvgpr
eparationsvgwithvgthevgsamevgnamevghavevgthevgsamevguniformvg strength,vgquality,vgand
vgpurity.vgTryvgagain.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgChoice
HASvgVARIABLES:v g False
DATEvgCREATED: 11/26/2017vg8:23vgPM
DATEvgMODIFIED:v g 11/26/2017vg8:31vgPM
4. ThevgFDA,vgundervgthevgdirectionvgofvgthevgDepartmentvgofvgHealthvgandvgHumanvgServices,vg mandatesvgwhi
chvgofvgthevgfollowing?
a. Prescriptionvgandvgnonprescriptionvgdrugsvgmustvgbevgshownvgtovgbevgeffectivevgasvgwellvgasvgsafe.
b. Allvglabelsvgmustvgincludevgavglistingvgofvgactivevgingredients;vgsomevglabelsvgrequirevgavglistingvgof
vginactivevgingredientsvgasvgwell.
c. AllvgnewvgproductsvgmustvgbevgtestedvgbyvgthevgFDAvgbeforevgbeingvgreleasedvgtovgthevgpublic.
d. Allvgdrugsvgmustvghavevg"warning"vglabels.
ANSWER: a
FEEDBACK:
a.vgPrescriptionvgandvgnonprescriptionvgdrugsvgmustvgbevgshownvgtovgbevgeffectivevgasvgwellvgasvgsa
fe.
b. Allvglabelsvgmustvgbevgaccuratevgandvgmustvgincludevgavglistingvgofvgallvgactivevga
ndvginactivevgingredients.vgTryvgagain.
c. ThevgFDAvgmustvgapprovevgallvgnewvgproductsvgbeforevgtheyvgarevgreleasedvgtovgthevg
public.vgTryvgagain.
d. Warningvglabelsvgmustvgbevgpresentvgonvgcertainvgpreparations.vgTryvgagain.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgChoice
CopyrightvgCengagevgLearning.vgPoweredvgbyvgCog Pagevg2
nero.
,Name: Class: Date:vg
Chaptervg1vgConsumervgSafetyvgandvgDrugvgRegulat
HAS
ions vgVARIABLES:v g False
DATEvgCREATED: 11/26/2017vg8:26vgPM
DATEvgMODIFIED:v g 11/26/2017vg8:30vgPM
5. Anvgoldervgadultvgclientvg isvgreluctantvgtovgtakevganyvgprescribedvgmedicationsvgandvgquestionsvgthevgnursevgaboutvgthe
CopyrightvgCengagevgLearning.vgPoweredvgbyvgCog Pagevg3
nero.
, Name: Class: Date:vg
Chaptervg1vgConsumervgSafetyvgandvgDrugvgRegulat
ions
productionvgprocessvgandvgsafetyvgofvghervgmedications.vgHowvgshouldvgthevgnursevgrespond?
a. FederalvglawsvgrequirevgallvgdrugsvgmarketedvginvgthevgUnitedvgStatesvgtovgmeetvgthevgminimalvgsta
ndardsvgofvgstrength,vgpurity,vgandvgquality.
b. MostvgmedicationsvgarevgmadevgoutsidevgthevgUnitedvgStates.
c. Pharmaceuticalvgcompaniesvgfollowvgtheirvgownvgguidelines.
d. Insurancevgcarriersvgsetvgthevgparametersvgforvgdrugvgmanufacturing.
ANSWER: a
FEEDBACK:
a.vgFederalvglawsvgrequirevgallvgdrugsvgmarketedvginvgthevgUnitedvgStatesvgtovgme
etvgthevgminimalvgstandardsvgofvg strength,vgpurity,vgandvgquality.
b. MedicationsvgmadevgoutvgofvgthevgUnitedvgStatesvgorvgillegallyvgarevgnotvgcontrolle
dvgbyvgdrugvgstandards.vgTryvgagain.
c. Althoughvgpharmaceuticalvgcompaniesvgdovghavevgguidelines,vgthevgfinalvgauthoriza
tionvgforvgreleasedvgproductsvgisvgthroughvgthevgFDA.vgTryvgagain.
d. Insurancevgcarriersvgdovgnotvgmanufacturevgmedications.vgTryvgagain.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgChoice
HASvgVARIABLES:v g False
DATEvgCREATED: 11/26/2017vg8:33vgPM
DATEvgMODIFIED:v g 11/26/2017vg8:35vgPM
6. Thevgnursevginvgthevglocalvgdrugvgpreventionvgclinicvgisvgaskedvgbyvgavgclientvgaboutvgthevgrelativevgdangervgofvgva
riousvgdrugs.vgShevgexplainsvgthatvgthevgDrugvgEnforcementvgAdministrationvg(DEA)vgclassifiesvgdrugsvgthatvgcanvg
bevgabusedvgorvghavevgaddictivevgpropertiesvgintovgcategoriesvgorvgschedules.vgWhichvgofvgthevgfollowingvgarevgfact
orsvgthatvgarevgconsideredvgwhenvgclassifyingvgthevgschedulevgofvgavgparticularvgdrug?vg(SELECTvg ALLvgTHATvgA
PPLY.)
a. thevgpotentialvgcostvgtovgproducevgthevgdrug
b. thevgmedicalvgvaluevgofvgthevgdrug
c. thevgharmfulnessvgofvgthevgdrug
d. thevgpotentialvgforvgabusevgorvgaddiction
e. thevgpopularityvgofvgthevgmedication
ANSWER: b,vgc,vgd
FEEDBACK: a.vgThevgcostvgtovgproducevgavgdrugvgisvgnotvgavgcategoryvgclassifiedvgbyvgthevgDEA.
b. ThevgDrugvgEnforcementvgAdministrationvgdividesvgcontrolledvgsubstancesvgintovgfivevgl
evelsvgorvgschedulesvgaccordingvgtovgtheirvgmedicalvgvalue.
c. Harmfulnessvgofvg avgdrugvgisvgonevgcriterionvgthatvgthevgDEAvgusesvgtovgcategorizevgavgdrug.
d. PotentialvgforvgabusevgisvgonevgcriterionvgthatvgthevgDEAvgusesvgtovgcategorizevgdrugs.
e. Thevgpopularityvgofvgthevgmedicationvgisvgnotvgconsidered.vgThevgDEAvgdoesvgtakevgintovg
considerationvgsocietalvgproblemsvgwithvgmedicationvgandvgthatvgmayvgcausevgthevgmedi
cationvgtovgbevgmovedvgfromvgonevgschedulevgtovganother.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgResponse
HASvgVARIABLES:v g False
DATEvgCREATED: 11/28/2017vg2:43vgAM
CopyrightvgCengagevgLearning.vgPoweredvgbyvgCog Pagevg4
nero.
Chaptervg1vgConsumervgSafetyvgandvgDrugvgRegulat
ions
1. Avgclientvgcallsvghervgprimaryvgcarevgprovidervgrequestingvgavgprescriptionvgforvganvgantidepressantvgmedication.vg
Shevgtellsvgthevgnursevgthatvgshevgisvgseverelyvgdepressedvgandvgwouldvglikevgthevgprescriptionvgcalledvginvgtovghervgloc
alvgpharmacy.vgHowvgshouldvgthevgnursevgrespond?
a. Thevgnursevgencouragesvgthevgclientvgtovgseevgavgpsychiatricvgprofessionalvgforvganvgevaluationvgtovg
obtainvgthevgprescription.
b. Thevgnursevgtellsvgthevgclientvgtovgaskvgthevgpharmacistvgtovgrecommendvganvgover-the-countervgantidepressant.
c. Thevgnursevgcanvgoffervgtovgwritevgthevgclientvgavgprescriptionvgifvgitvg isvgavgrefill.
d. Thevgnursevgoffersvgtovggivevgthevgclientvgavgfewvgsamplesvgtovgusevguntilvghervgnextvgappointment.
ANSWER: a
FEEDBACK:
a.vgThevgclientvgshouldvgbevgencouragedvgtovgseekvgavgpsychiatricvgprofessionalvgevalu
ationvgtovgobtainvgthevgprescription.
b. Antidepressantsvgarevgnotvgsoldvgasvgover-the-
countervgmedications;vgavgprescriptionvgisvgrequired.vgTryvgagain.
c. Thevgnursevgcannotvgwritevgavgprescriptionvgwithoutvgevaluatingvgthevgclient.vgTryvgagain.
d. Samplesvgarevgnotvggivenvgoutvgtovgavgclientvgwhovghasvgnotvgbeenvgevaluatedvgbyvgavgpra
ctitioner.vgTryvgagain.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgChoice
HASvgVARIABLES:v g False
DATEvgCREATED: 11/26/2017vg8:16vgPM
DATEvgMODIFIED:v g 11/26/2017vg8:32vgPM
2. Avgclientvgvisitsvghervghealthvgcarevgprovidervgforvghervgannualvgphysical.vgShevgquestionsvgthevgnursevgregardingv
gthevgusevgofvganvgherbalvgsupplementvgthatvgshevgsawvgadvertisedvgonvgtelevisionvgforvgweightvgloss.vgWhatvginforma
tionvgcanvgthevgnursevgsharevgwithvghervgclient?
a. ThevgproductionvgofvgherbalvgmedicinesvgisvgnotvgregulatedvgbyvgthevgFDA.
b. UndervgthevgDietaryvgSupplementvg HealthvgandvgEducationvgActvgofvg1994vg(DSHEA),vgthevgFDAvgisvgres
ponsiblevgforvgensuringvgthatvg avgdietaryvgsupplementvg isvgsafevgbeforevgitvgisvgmarketed.
c. HerbalvgmedicinesvgarevgtestedvgbyvgthevgFDAvgtovgdeterminevgifvgtheyvghavevginteractionsvgwithvgpr
escribedvgmedications.
d. Herbalvgmedicines,vgwhilevgnotvgapprovedvgbyvgthevgFDA,vgarevgconsideredvgharmless.
ANSWER: a
FEEDBACK: a.vgThevgproductionvgofvg herbalvgmedicinesvgisvgnotvgregulatedvgbyvgthevgFDA.
b. UndervgthevgDietaryvgSupplementvgHealthvgandvgEducationvgActvgofvg1994vg(DSHEA),vgt
hevgdietaryvgmanufacturervgisvgresponsiblevgforvgensuringvgthatvgavgdietaryvgsupplementvgi
svgsafevgbeforevgitvgisvgmarketed.vgTryvgagain.
c. ThevgFDAvgdoesvgnotvgtestvgsupplements.vgTryvgagain.
d. Therevgarevgdocumentedvginteractionsvgwithvgspecificvgherbalvgsupplementsvgandvgpre
scribedvgmedications.vgTryvgagain.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgChoice
HASvgVARIABLES:v g False
DATEvgCREATED: 11/26/2017vg8:22vgPM
DATEvgMODIFIED:v g 11/26/2017vg8:32vgPM
CopyrightvgCengagevgLearning.vgPoweredvgbyvgCog Pagevg1
nero.
,Name: Class: Date:vg
Chaptervg1vgConsumervgSafetyvgandvgDrugvgRegulat
ions
3. Uponvgleavingvgthevgexamvgroom,vgavgclientvgtellsvgthevgnursevgthatvgshevgisvgconfusedvgregardingvghervgprescription.
Shevgasksvgthevgnursevgifvgavgcheaper,vggenericvgdrugvgwillvgbevgweakervgthanvghervgcurrentvgprescription.vgHowvgshou
vg
ldvgthevgnursevgrespond?
a. Drugvgstandardsvgassurevgconsumersvgthatvgthevgsamevgdrugvgmustvgbevgofvguniformvgstrength,vgquality,vgandvgpur
ity.
b. Thevgprescribedvgmedicationvgisvgofvgbettervgqualityvgbutvgwillvgcostvgmore.
c. Thevginsurancevgcompaniesvgmandatevgtherevgarevgdifferentvgstrengthsvgbetweenvggenericvgandvgbran
dvgnamevgprescriptions.
d. Everyvgdrugvghasvgavgdifferentvgchemicalvgcompositionvgthatvgcannotvgbevgduplicated.
ANSWER: a
FEEDBACK:
a.vgDrugvgstandardsvgassurevgconsumersvgthatvgthevgsamevgdrugvgmustvgbevgofvgun
iformvgstrength,vgquality,vgandvgpurity.
b. Genericvgandvgtradevgdrugsvgarevgthevgsamevgmedication.vgGenericvgisvgthevgnamevgthatvgi
svgassignedvgtovgavgnewvgdrug.vgThevgtradevgnamevgisvgthevgnamevgthevgpharmaceuticalvgco
mpanyvgassignsvgtovgthatvgdrugvgtovghavevgexclusivevgrightsvgtovgmarketvgit.vgTryvgagain.
c. Insurancevgcompaniesvghavevgnovgcontrolvgovervgthevgproductionvgofvgmedication.vgTryvgagain.
d. Thevglawsvgregulatingvgdrugsvgstatevgthatvgconsumersvgcanvgbevgassuredvgthatvgallvgpr
eparationsvgwithvgthevgsamevgnamevghavevgthevgsamevguniformvg strength,vgquality,vgand
vgpurity.vgTryvgagain.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgChoice
HASvgVARIABLES:v g False
DATEvgCREATED: 11/26/2017vg8:23vgPM
DATEvgMODIFIED:v g 11/26/2017vg8:31vgPM
4. ThevgFDA,vgundervgthevgdirectionvgofvgthevgDepartmentvgofvgHealthvgandvgHumanvgServices,vg mandatesvgwhi
chvgofvgthevgfollowing?
a. Prescriptionvgandvgnonprescriptionvgdrugsvgmustvgbevgshownvgtovgbevgeffectivevgasvgwellvgasvgsafe.
b. Allvglabelsvgmustvgincludevgavglistingvgofvgactivevgingredients;vgsomevglabelsvgrequirevgavglistingvgof
vginactivevgingredientsvgasvgwell.
c. AllvgnewvgproductsvgmustvgbevgtestedvgbyvgthevgFDAvgbeforevgbeingvgreleasedvgtovgthevgpublic.
d. Allvgdrugsvgmustvghavevg"warning"vglabels.
ANSWER: a
FEEDBACK:
a.vgPrescriptionvgandvgnonprescriptionvgdrugsvgmustvgbevgshownvgtovgbevgeffectivevgasvgwellvgasvgsa
fe.
b. Allvglabelsvgmustvgbevgaccuratevgandvgmustvgincludevgavglistingvgofvgallvgactivevga
ndvginactivevgingredients.vgTryvgagain.
c. ThevgFDAvgmustvgapprovevgallvgnewvgproductsvgbeforevgtheyvgarevgreleasedvgtovgthevg
public.vgTryvgagain.
d. Warningvglabelsvgmustvgbevgpresentvgonvgcertainvgpreparations.vgTryvgagain.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgChoice
CopyrightvgCengagevgLearning.vgPoweredvgbyvgCog Pagevg2
nero.
,Name: Class: Date:vg
Chaptervg1vgConsumervgSafetyvgandvgDrugvgRegulat
HAS
ions vgVARIABLES:v g False
DATEvgCREATED: 11/26/2017vg8:26vgPM
DATEvgMODIFIED:v g 11/26/2017vg8:30vgPM
5. Anvgoldervgadultvgclientvg isvgreluctantvgtovgtakevganyvgprescribedvgmedicationsvgandvgquestionsvgthevgnursevgaboutvgthe
CopyrightvgCengagevgLearning.vgPoweredvgbyvgCog Pagevg3
nero.
, Name: Class: Date:vg
Chaptervg1vgConsumervgSafetyvgandvgDrugvgRegulat
ions
productionvgprocessvgandvgsafetyvgofvghervgmedications.vgHowvgshouldvgthevgnursevgrespond?
a. FederalvglawsvgrequirevgallvgdrugsvgmarketedvginvgthevgUnitedvgStatesvgtovgmeetvgthevgminimalvgsta
ndardsvgofvgstrength,vgpurity,vgandvgquality.
b. MostvgmedicationsvgarevgmadevgoutsidevgthevgUnitedvgStates.
c. Pharmaceuticalvgcompaniesvgfollowvgtheirvgownvgguidelines.
d. Insurancevgcarriersvgsetvgthevgparametersvgforvgdrugvgmanufacturing.
ANSWER: a
FEEDBACK:
a.vgFederalvglawsvgrequirevgallvgdrugsvgmarketedvginvgthevgUnitedvgStatesvgtovgme
etvgthevgminimalvgstandardsvgofvg strength,vgpurity,vgandvgquality.
b. MedicationsvgmadevgoutvgofvgthevgUnitedvgStatesvgorvgillegallyvgarevgnotvgcontrolle
dvgbyvgdrugvgstandards.vgTryvgagain.
c. Althoughvgpharmaceuticalvgcompaniesvgdovghavevgguidelines,vgthevgfinalvgauthoriza
tionvgforvgreleasedvgproductsvgisvgthroughvgthevgFDA.vgTryvgagain.
d. Insurancevgcarriersvgdovgnotvgmanufacturevgmedications.vgTryvgagain.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgChoice
HASvgVARIABLES:v g False
DATEvgCREATED: 11/26/2017vg8:33vgPM
DATEvgMODIFIED:v g 11/26/2017vg8:35vgPM
6. Thevgnursevginvgthevglocalvgdrugvgpreventionvgclinicvgisvgaskedvgbyvgavgclientvgaboutvgthevgrelativevgdangervgofvgva
riousvgdrugs.vgShevgexplainsvgthatvgthevgDrugvgEnforcementvgAdministrationvg(DEA)vgclassifiesvgdrugsvgthatvgcanvg
bevgabusedvgorvghavevgaddictivevgpropertiesvgintovgcategoriesvgorvgschedules.vgWhichvgofvgthevgfollowingvgarevgfact
orsvgthatvgarevgconsideredvgwhenvgclassifyingvgthevgschedulevgofvgavgparticularvgdrug?vg(SELECTvg ALLvgTHATvgA
PPLY.)
a. thevgpotentialvgcostvgtovgproducevgthevgdrug
b. thevgmedicalvgvaluevgofvgthevgdrug
c. thevgharmfulnessvgofvgthevgdrug
d. thevgpotentialvgforvgabusevgorvgaddiction
e. thevgpopularityvgofvgthevgmedication
ANSWER: b,vgc,vgd
FEEDBACK: a.vgThevgcostvgtovgproducevgavgdrugvgisvgnotvgavgcategoryvgclassifiedvgbyvgthevgDEA.
b. ThevgDrugvgEnforcementvgAdministrationvgdividesvgcontrolledvgsubstancesvgintovgfivevgl
evelsvgorvgschedulesvgaccordingvgtovgtheirvgmedicalvgvalue.
c. Harmfulnessvgofvg avgdrugvgisvgonevgcriterionvgthatvgthevgDEAvgusesvgtovgcategorizevgavgdrug.
d. PotentialvgforvgabusevgisvgonevgcriterionvgthatvgthevgDEAvgusesvgtovgcategorizevgdrugs.
e. Thevgpopularityvgofvgthevgmedicationvgisvgnotvgconsidered.vgThevgDEAvgdoesvgtakevgintovg
considerationvgsocietalvgproblemsvgwithvgmedicationvgandvgthatvgmayvgcausevgthevgmedi
cationvgtovgbevgmovedvgfromvgonevgschedulevgtovganother.
POINTS: 1
QUESTIONvgTYPE:v g MultiplevgResponse
HASvgVARIABLES:v g False
DATEvgCREATED: 11/28/2017vg2:43vgAM
CopyrightvgCengagevgLearning.vgPoweredvgbyvgCog Pagevg4
nero.
